Similac Advance
This article was originally published in The Tan Sheet
Executive Summary
Ross Products' DHA-, ARA-fortified infant formula will be marketed under Martek Bioscience's GRAS affirmation, granted in May, for algae-derived fatty acids, both companies confirmed. Abbott Labs division's own GRAS petition for tuna-derived DHA, filed Jan. 2, is still pending at FDA, contrary to a report in 1"The Tan Sheet" Feb. 25, 2002, In Brief...
You may also be interested in...
Similac Advance
Ross Products' infant formula fortified with Martek Biosciences' DHA, ARA fatty acid oils will be available by mid-April in food, drug, mass stores, Abbott Labs division says. Advance will come in 12.9 oz. and 25.7 oz. powder, 32 oz. ready-to-feed plastic bottle; formula will be priced at 15% premium over existing products. Ross says it has received FDA clearance for its GRAS petition, submitted Jan. 2; firm will be second to market fortified formula in the U.S. following Mead Johnson's launch of Enfamil LIPIL, reaching shelves this month (1"The Tan Sheet" Jan. 14, 2002, p. 3)...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.